Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Growth in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 116,100 shares, a growth of 1,175.8% from the November 30th total of 9,100 shares. Approximately 8.5% of the company’s stock are short sold. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Arcadia Biosciences in a report on Wednesday. They set a “sell” rating for the company.

Arcadia Biosciences Stock Up 0.3 %

Shares of Arcadia Biosciences stock traded up $0.02 on Thursday, hitting $6.20. 36,565 shares of the company’s stock traded hands, compared to its average volume of 316,571. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The stock has a market cap of $8.46 million, a P/E ratio of -1.45 and a beta of 1.19. The firm’s 50-day moving average is $4.30 and its 200 day moving average is $3.39.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.